![Friedrich von Bohlen und Halbach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Friedrich von Bohlen und Halbach
Président chez
OREXO AB
Fortune : 47 116 $ au 30/06/2026
Profil
Friedrich von Bohlen und Halbach founded Lion Bioscience AG in 1997, where he worked as Chief Executive Officer from 1997 to 2003 and Molecular Health GmbH in 2004, where he is working as Chief Executive Officer & Managing Director.
Dr. von Bohlen und Halbach also founded Posbelduf Biotech AG, where he worked as Chairman & Chief Executive Officer.
Dr. von Bohlen und Halbach also currently works at Apogenix AG, as Chairman-Supervisory Board, Molecular Health, Inc., as Executive Chairman, Novaliq GmbH, as Chairman-Supervisory Board, and various other companies.
Dr. von Bohlen und Halbach also formerly worked at GPC Biotech AG, as Chief Executive Officer, Wasag Chemie AG, as Chief Executive Officer from 1994 to 1997, 2invest AG, as Deputy Chairman-Supervisory Board, and various other companies.
Dr. von Bohlen und Halbach received his doctorate degree in 1992 from Swiss Federal Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OREXO AB 0,05 % | 31/12/2025 | 19 000 ( 0,05 % ) | 47 116 $ | 30/06/2026 |
Postes actifs de Friedrich von Bohlen und Halbach
| Sociétés | Poste | Début |
|---|---|---|
| OREXO AB | Président | 08/05/2025 |
Molecular Health GmbH
 Molecular Health GmbH Packaged SoftwareTechnology Services Provides data-driven software technology solutions for transforming biomedical data into actionable insights | Directeur Général | 01/01/2004 |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Directeur/Membre du Conseil | - |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Develops and markets drug delivery systems | Président | - |
Innosource Ventures AG | Président | - |
Max Planck Institute For Medical Research
 Max Planck Institute For Medical Research Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases | Président | - |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions | Président | - |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Directeur/Membre du Conseil | - |
| ░░░░ ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Friedrich von Bohlen und Halbach
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ ░░░░ ░░░░░ ░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Friedrich von Bohlen und Halbach
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
37
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 37 |
|---|---|
Fresenius SE & Co. KGaA
 Fresenius SE & Co. KGaA Hospital/Nursing ManagementHealth Services Develops and manufactures generic drugs, biopharmaceuticals, infusion & nutrition therapies and medical devices | Health Services |
2invest AG
 2invest AG Financial ConglomeratesFinance Operates as an investment holding company primarily investing in biotechnology | Finance |
AC Immune SA
 AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
Cosmo Pharmaceuticals SA
 Cosmo Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company | Health Technology |
CureVac SE
 CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Health Technology |
GPC Biotech AG
 GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs | Commercial Services |
Wasag Chemie AG
 Wasag Chemie AG Chemicals: SpecialtyProcess Industries Manufactures chemicals, plastics, and explosives | Process Industries |
Integrated Diagnostics, Inc.
 Integrated Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a molecular diagnostics company | Health Services |
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Heidelberg Pharma AG
 Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Curacyte AG
 Curacyte AG Miscellaneous Commercial ServicesCommercial Services Develops biopharmaceutical drugs | Commercial Services |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Health Technology |
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Private Life BioMed AG
 Private Life BioMed AG Investment ManagersFinance Private Life BioMed invests in early- and growth-stage biotechnology companies. The firm focuses on businesses developing innovative diagnostics and drug development technologies. They generally co-invest with large syndicates and may participate in several rounds. | Finance |
Fachhochschule Ludwigshafen am Rhein
 Fachhochschule Ludwigshafen am Rhein Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cosmo Holding SpA
 Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Apogenix AG
Apogenix AG BiotechnologyHealth Technology Develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases | Health Technology |
febit holding GmbH
 febit holding GmbH Medical/Nursing ServicesHealth Services Designs and develops technologies for DNA analysis | Health Services |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech hldg invests in companies located in Germany. The firm focuses on the biotechnology sectors and industries. It provides financing for early stage capital requirements. | Finance |
Agennix AG
 Agennix AG BiotechnologyHealth Technology Discovers, develops and commercializes new anti-cancer drugs | Health Technology |
Febit, Inc. | |
Heidelberg Pharma AG /Old/
 Heidelberg Pharma AG /Old/ Miscellaneous Commercial ServicesCommercial Services Provides drug development services | Commercial Services |
Weinheim 216 GmbH & Co. KG
 Weinheim 216 GmbH & Co. KG BiotechnologyHealth Technology Engage in biological research | Health Technology |
Cosmo Bioscience SpA | |
Posbelduf Biotech AG
 Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Provides clinico-molecular informatic solutions | Health Technology |
Lion Bioscience AG | |
dievini Verwaltungs GmbH | |
Molecular Health GmbH
Molecular Health GmbH Packaged SoftwareTechnology Services Provides data-driven software technology solutions for transforming biomedical data into actionable insights | Technology Services |
Molecular Health, Inc.
Molecular Health, Inc. Packaged SoftwareTechnology Services Operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions | Technology Services |
Novaliq GmbH
Novaliq GmbH Medical SpecialtiesHealth Technology Develops and markets drug delivery systems | Health Technology |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Health Technology |
Cosmo Pharmaceuticals NV
 Cosmo Pharmaceuticals NV Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for gastrointestinal diseases and dermatology | Health Technology |
Wyss Translational Center Zurich | |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
Innosource Ventures AG | |
Max Planck Institute For Medical Research
Max Planck Institute For Medical Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
